An Attention-Restorative Therapy (ART)-Based Virtual Reality Intervention to Address Cancer-Related Cognitive Impairments Among Breast Cancer Survivors

Inclusion Criteria

• •Female
• •Age ≥18
• •Stage I-III breast cancer
• •Reports a negative change in cognitive function since their cancer diagnosis and rate their cognitive fatigue using a single item questions as a ≥4 on a numeric rating scale of 0-10 for 1 month or more.
• •Completed primary treatment (chemotherapy, radiation and/or surgery) ≥ 3 months but no more than 10 years prior to registration.
• •May use concurrent adjuvant endocrine therapy and/or HER2-targeted therapy while on study.
• •Ability to provide informed written consent.
• •Ability to read and write English.
• •Ability to be independent in decision making. Must respond No to "Do you have a guardian or blanket power of attorney for legal transactions?"
• •Chronic oral or intravenous systemic steroid use (defined as being used on a regular basis or who have a problem that has required ongoing use of steroids in the last 180 days for greater than 7 days).
• •Psychiatric disorder such as severe depression, bipolar disorder, obsessive compulsive disorder or schizophrenia. (Defined per medical history and/or patient self-report.)
• •Pain requiring opioid pain medication.
• •Electronic implanted medical device (e.g. pacemaker).
• •History of motion sickness within 5 years prior to enrollment will require a tolerability test at baseline.